Alomone AGC-003-50UL 说明书

世界*实验材料供应商Alomone上海金畔生物为其中国代理,Alomone在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品,的服务,Alomone就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

Alomone中国代理,Alomone上海代理,Alomone北京代理,Affinity  Biologicals广东代理,Alomone江苏代理Alomone湖北代理,Alomone天津,Alomone黑龙江代理,Alomone内蒙古代理,Alomone吉林代理,Affinity  Biologicals福建代理,Alomone江苏代理,Alomone浙江代理,Affinity Biological四川代理,

 

Alomone 公司是一家位于耶路撒冷的以色列的生物科技公司,专著于提供生命科学细胞生物学试剂和服务。

Alomone 公司作为世界上zui的离子通道专业供应商,它的离子通道抗体是世界上zui全的、质量也非常好!目前被世界各地的科学家广泛的使用。

Anti-NMDA Receptor 2A (GluN2A) (extracellular)

Ionotropic Glutamate receptor subunit ε1, N-methyl-D-aspartate receptor subunit 2A, GRIN2A, GLUN2A
    • Cat #: AGC-002
    • Size: 25 µl, 50 µl, 0.2 ml
    • Source: Rabbit
    • Type: Polyclonal

    一般信息

    Alomone Labs is pleased to offer a highly specific antibody directed against an extracellular epitope of rat GluN2A. Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody (#AGC-002) can be used in western blot, immunoprecipitation, immunocytochemistry, and immunohistochemistry. The antibody recognizes an extracellular epitope and is thus ideal for detecting GluN2A in living cells. It has been designed to recognize NR2A from rat, mouse, and human samples.

    Related products for control experiments:
    Control peptide antigen (supplied with the antibody free of charge).

    Anti-NMDA Receptor 2A (GluN2A) antibody (#AGC-002) in the literature: 
    Western blot analysis (WB):
    – Mouse brain lysate (1:2000) (see Konstantoudaki, X. et al. (2016) in Product Citations).
    – Mouse hippocampus lysate (1:1000) (see Tindi, J.O. et al. (2015) in Product Citations).
    – Mouse brain lysate (1:500) (see Atkin, G. et al. (2015) in Product Citations).

    Immunohistochemistry (IH):
    – Mouse brain sections (1:100) (see Atkin, G. et al. (2015) in Product Citations).

    Immunocytochemistry (IC):
    – Human induced pluripotent stem cells (1:300) (see ezhkin, V. et al. (2016) in Product Citations).
    – Mouse hippocampal neurons (see Atkin, G. et al. (2015) in Product Citations).
    – Rat cultured hippocampal neurons (1:100) (see Swanger, S.A. et al. (2013) in Product Citations).

    Live cell imaging (LCI):
    – Rat hippocampal neurons (see Dupuis, J.P. et al. (2014) in Product Citations).
    – Rat hippocampal primary neurons (1:500) (see Mikasova, L. et al. (2012) in Product Citations).

     

    Western blot
    Western blot analysis of rat brain lysates:
    1. Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody (#AGC-002), (1:600).
    2. Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody, preincubated with the control peptide antigen.
    Live cell imaging / Immunocytochemistry
    Rat live C6 glioma cells (1:100). See immunocytochemistry.
     
    Immunoprecipitation
    Immunoprecipitation of rat brain lysates
    1. Cell lysate.
    2. Cell lysates + protein A beads + Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody (#AGC-002).
    3. Cell lysates + protein A beads + pre-immune rabbit serum. 

    Black arrow indicates the NMDA Receptor 2A protein while the red arrow shows the IgG heavy chain. Immunoblot was performed with Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody.

    Immunohistochemistry
    Immuno-colocalization of GluN2A and GluN2B in mouse deep cerebellar nucleus
    Immunohistochemical staining of perfusion-fixed frozen mouse brain sections using Anti-NMDA Receptor 2B (GluN2B) (extracellular)-ATTO-594 antibody (#AGC-003-AR), (1:60) and Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody (#AGC-002), (1:200). A. Sections were incubated with Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody, followed by goat anti-rabbit-Alexa-488 (green). B. The same sections were incubated with Anti-NMDA Receptor 2B (GluN2B) (extracellular)-ATTO-594 antibody (red). C. Merge of A and B demonstrates the ubiquitous colocalization of the GluN2A and GluN2B subunits in cells with neuronal profiles in this nucleus.  Arrows point at an example of NR2A and NR2B co-expression.
    Expression of NMDA Receptor 2A in rat hippocampus
    Immunohistochemical staining of  rat hippocampal dentate gyrus with Anti-NMDA Receptor 2A (GluN2A) (extracellular) antibody (#AGC-002). A. NMDA Receptor 2A (green) appears diffusely in the outer molecular layer of the dentate gyrus (Out Mol.) and in cells along the subgranular layer (arrows). B. Staining of parvalbumin (PV, red) identifies interneurons in the dentate gyrus. C. Confocal merge demonstrates localization of PV in some neurons with NMDA Receptor 2A.
    Immunocytochemistry
    Expression of NMDA Receptor 2A in rat C6 glioma cells
    Immunocytochemical staining of live intact rat C6 glioma cells.
    A. Cells were stained with Anti-NMDA Receptor 2A (GluN2A) (extracellular)antibody (#AGC-002), (1:100), followed by goat anti-rabbit-AlexaFluor-555 secondary antibody (red). Cell nuclei were stained with the cell permeable dye Hoechst 33342 (blue staining). B. Live view of the same field.

     

     

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

    产品说明书

    FAQ

    COA

    已发表文献

     

    AT13148 (AT13148)是新型可口服的、ATP竞争性多AGC kinase抑制剂,具有强大的药效学和抗肿瘤活性。AT13148Akt1/2/3PKAp70S6KROCKI/IIIC50分别为38 nM/402 nM/50 nM3 nM8 nM6 nM/4 nM,与其他AKT抑制剂作用机制不同,同时抑制多种AGC激酶可能会增加抗肿瘤活性并最大限度地减少临床耐药性。

     

    产品性质

    英文别名 (English Synonym)

    AT13148, AT13148

    靶点 (Target)

    Akt1/2/3, p70S6K, PKA, ROCKI/II

    通路 (Pathway)

    PI3K/Akt/mTOR–Akt

    CAS (CAS NO.)

    1056901-62-2

    分子式 (Formula)

    C17H16ClN3O

    分子量 (Molecular Weight)

    313.78

    外观 (Appearance)

    粉末

    纯度 (Purity)

    ≥98%

    溶解性 (Solubility)

    溶于DMSO

    结构式 (Structure)

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

     

    运输和保存方法

    冰袋运输。粉末直接保存于-20℃,有效期3年。建议分装后-20℃干燥保存,避免反复冻融。

     

    注意事项

    1. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

    2. 粉末溶解前请先短暂离心,以保证产品全在管底。

    3. 请勿吸入、吞咽或者直接接触皮肤和眼睛。

    4. 本产品仅用于科研用途,禁止用于人身上。

     

    使用浓度

    【具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。

     

    使用方法(数据来自于公开发表的文献,仅供参考)

    细胞实验(体外实验)

     AT13148,作为多重AGC激酶抑制剂,有效抑制癌细胞增殖,对PI3K-AKT-mTORRAS-RAF通路反常的癌细胞系,GI50值为1.53.8 μM。在PTEN缺陷型MES-SA细胞中,AT13148也会抑制AKTp70S6K信号[1] 

    动物实验(体实验)

    在人肿瘤MES-SABT474PC3异种移植物中,AT13148 (50 mg/kg p.o.)显著抑制AKTp70S6K AGC激酶的活性,并表现出显著的抗肿瘤作用。[1] HGC27异种移植的小鼠模型中,AT13148 (15-45 mg/kg p.o.)显著抑制瘤体生长。[2] 

     

    参考文献

    1.Yap TA, et al. AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity. Clin Cancer Res. 2012 Jul 15;18(14):3912-23.

    2.Xi Y, et al. AT13148, a first-in-class multi-AGC kinase inhibitor, potently inhibits gastric cancer cells both in vitro and in vivo. Biochem Biophys Res Commun. 2016 Sep 9;478(1):330-6.

    HB221116

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

    暂无内容

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

    暂无内容

     

    AT13148 (AT13148)是新型可口服的、ATP竞争性多AGC kinase抑制剂,具有强大的药效学和抗肿瘤活性。AT13148Akt1/2/3PKAp70S6KROCKI/IIIC50分别为38 nM/402 nM/50 nM3 nM8 nM6 nM/4 nM,与其他AKT抑制剂作用机制不同,同时抑制多种AGC激酶可能会增加抗肿瘤活性并最大限度地减少临床耐药性。

     

    产品性质

    英文别名 (English Synonym)

    AT13148, AT13148

    靶点 (Target)

    Akt1/2/3, p70S6K, PKA, ROCKI/II

    通路 (Pathway)

    PI3K/Akt/mTOR–Akt

    CAS (CAS NO.)

    1056901-62-2

    分子式 (Formula)

    C17H16ClN3O

    分子量 (Molecular Weight)

    313.78

    外观 (Appearance)

    粉末

    纯度 (Purity)

    ≥98%

    溶解性 (Solubility)

    溶于DMSO

    结构式 (Structure)

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

     

    运输和保存方法

    冰袋运输。粉末直接保存于-20℃,有效期3年。建议分装后-20℃干燥保存,避免反复冻融。

     

    注意事项

    1. 为了您的安全和健康,请穿实验服并戴一次性手套操作。

    2. 粉末溶解前请先短暂离心,以保证产品全在管底。

    3. 请勿吸入、吞咽或者直接接触皮肤和眼睛。

    4. 本产品仅用于科研用途,禁止用于人身上。

     

    使用浓度

    【具体使用浓度请参考相关文献,并根据自身实验条件(如实验目的,细胞种类,培养特性等)进行摸索和优化。

     

    使用方法(数据来自于公开发表的文献,仅供参考)

    细胞实验(体外实验)

     AT13148,作为多重AGC激酶抑制剂,有效抑制癌细胞增殖,对PI3K-AKT-mTORRAS-RAF通路反常的癌细胞系,GI50值为1.53.8 μM。在PTEN缺陷型MES-SA细胞中,AT13148也会抑制AKTp70S6K信号[1] 

    动物实验(体实验)

    在人肿瘤MES-SABT474PC3异种移植物中,AT13148 (50 mg/kg p.o.)显著抑制AKTp70S6K AGC激酶的活性,并表现出显著的抗肿瘤作用。[1] HGC27异种移植的小鼠模型中,AT13148 (15-45 mg/kg p.o.)显著抑制瘤体生长。[2] 

     

    参考文献

    1.Yap TA, et al. AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity. Clin Cancer Res. 2012 Jul 15;18(14):3912-23.

    2.Xi Y, et al. AT13148, a first-in-class multi-AGC kinase inhibitor, potently inhibits gastric cancer cells both in vitro and in vivo. Biochem Biophys Res Commun. 2016 Sep 9;478(1):330-6.

    HB221116

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

    暂无内容

    AT13148(AT-13148) 多AGC kinase抑制剂|CAS 1056901-62-2

    暂无内容